Synthesis of N-methylated cyclic peptides

Nature Protocols

Volumn 7, Issue 3, 2012, Pages 432-444

  Chatterjee, Jayanta ^a,c   Laufer, Burkhardt ^a,d   Kessler, Horst ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE;

ARTICLE; CYCLIZATION; MEMBRANE PERMEABILITY; PEPTIDE SYNTHESIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN METHYLATION; PROTEIN STABILITY; STRUCTURE ANALYSIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CYCLIZATION; MASS SPECTROMETRY; METHYLATION; MOLECULAR STRUCTURE; PEPTIDES, CYCLIC;

EID: 84856924428     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2011.450     Document Type: Article

References (42)

1. Gilon, C., Dechantsreiter, M.A., Burkhart, F., Friedler, A. & Kessler, H. in Houben-Weyl Methods of Organic Chemistry, Vol. E22c (eds. Goodman, M., Felix, A., Moroder, L. & Tonolio, C.) 215-291 (Georg Thieme Verlag, 2002).
2. Hamman, J.H., Enslin, G.M. & Kotze, A.F. Oral delivery of peptide drugs: barriers and developments. Biodrugs 19, 165-177 (2005). (Pubitemid 40994232)
3. Kessler, H. Peptide Conformations. 19. Conformation and biological activity of cyclic-peptides. Angew. Chem. Int. Ed. 21, 512-523 (1982).
4. Hess, S. et al. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. J. Med. Chem. 51, 1026-1034 (2008). (Pubitemid 351304710)
5. Shemyakin, M.M., Ovchinnikov, Y.A. & Ivanov, V.T. Topochemical investigation of peptide systems. Angew. Chem. Int. Ed. Engl. 8, 492-499 (1969).
6. Goodman, M. & Chorev, M. Concept of linear modified retro-peptide structures. Acc. Chem. Res. 12, 1-7 (1979).
7. Giannis, A. Peptidomimetics for receptor ligands-discovery, development, and medical perspectives. Angew. Chem. Int. Ed. 32, 1244-1267 (1993).
8. Lee, H.K. et al. Anticonvulsant Met-enkephalin analogues containing backbone spacers reveal alternative non-opioid signaling in the brain. ACS Chem. Biol. 4, 659-671 (2009).
9. Simon, R.J. et al. Peptoids-a modular approach to drug discovery. Proc. Natl. Acad. Sci. USA 89, 9367-9371 (1992).
10. Kessler, H. Peptoids-a new approach to the development of pharmaceuticals. Angew. Chem. Int. Ed. Engl. 32, 543-544 (1993).
11. White, C.J. & Yudin, A.K. Contemporary strategies for peptide macrocyclization. Nat. Chem. 3, 509-524 (2011).
12. Rothbard, J.B. et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 6, 1253-1257 (2000).
13. Wender, P.A. et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA 97, 13003-13008 (2000).
14. Richard, J.P. et al. Cell-penetrating peptides-a re-evaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590 (2003). (Pubitemid 36043612)
15. Jones, S.W. et al. Characterisation of cell-penetrating peptide-mediated peptide delivery. Br. J. Pharmacol. 145, 1093-1102 (2005).
16. Borel, J.F., Feurer, C., Gubler, H.U. & Stahelin, H. Biological effects of Cyclosporin-a-new antilymphocytic agent. Agents Actions 6, 468-475 (1976).
17. Pettit, G.R. et al. Isolation of Dolastatins 10-15 from the marine mollusk Dolabella auricularia. Tetrahedron 49, 9151-9170 (1993).
18. Cruz, L.J. et al. IB-01212, a new cytotoxic cyclodepsipeptide isolated from the marine fungus Clonostachys sp. ESNA-A009. J. Org. Chem. 71, 3335-3338 (2006).
19. Plaza, A. et al. Mutremdamide A and koshikamides C-H, peptide inhibitors of HIV-1 entry from different Theonella species. J. Org. Chem. 75, 4344-4355 (2010).
20. Lipinski, C.A., Lombardo, F., Dominy, B.W. & Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3-26 (2001).
21. Sugano, H., Higaki, K. & Miyoshi, M. Synthesis and biological-activity of peptides related to eledoisin. 1. Hexapeptide amides containing alpha-hydroxy acids. Bull. Chem. Soc. Japan 46, 226-230 (1973).
22. Dechantsreiter, M.A. et al. N-methylated cyclic RGD peptides as highly active and selectivea(v)β(3) integrin antagonists. J. Med. Chem. 42, 3033-3040 (1999). (Pubitemid 29384038)
23. Mas-Moruno, C., Rechenmacher, F. & Kessler, H. Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anticancer Agents Med. Chem. 10, 753-768 (2011).
24. Haubner, R., Finsinger, D. & Kessler, H. Stereoisomeric peptide libraries and peptidomimetics for designing selective inhibitors of the avβ3 integrin for a new cancer therapy. Angew. Chem. Int. Ed. Engl. 36, 1374-1389 (1997).
25. Gordon, D.J., Tappe, R. & Meredith, S.C. Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits A β(1-40) fibrillogenesis. J. Pept. Res. 60, 37-55 (2002). (Pubitemid 34680830)
26. Kessler, H. Detection of intramolecular mobility by NMR spectroscopy. 13. Detection of hindered rotation and inversion by NMR spectroscopy. Angew. Chem. Int. Ed. 9, 219-235 (1970).
27. Chatterjee, J., Gilon, C., Hoffman, A. & Kessler, H. N-methylation of peptides: a new perspective in medicinal chemistry. Acc. Chem. Res. 41, 1331-1342 (2008).
28. Ovadia, O. et al. Improvement of drug-like properties of peptides: the somatostatin paradigm. Expert Opin. Drug Discov. 5, 655-671 (2010).
29. Chatterjee, J., Mierke, D.F. & Kessler, H. Conformational preference and potential templates of N-methylated cyclic pentaalanine peptides. Chem. Eur. J. 14, 1508-1517 (2008).
30. Laufer, B., Chatterjee, J., Frank, A.O. & Kessler, H. Can N-methylated amino acids serve as substitutes for prolines in conformational design of cyclic pentapeptides? J. Pept. Sci. 15, 141-146 (2009).
31. Chatterjee, J. et al. Multiple N-methylation by a designed approach enhances receptor selectivity. J. Med. Chem. 50, 5878-5881 (2007).
32. Chatterjee, J. et al. N-Methylated sst2 selective somatostatin cyclic peptide analogue as potent candidate for treating neurogenic inflammation. ACS Med. Chem. Lett. 2, 509-514 (2011).
33. Doedens, L. et al. Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies. J. Am. Chem. Soc. 132, 8115-8128 (2010).
34. Biron, E. et al. Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. Angew. Chem. Int. Ed. 47, 2595-2599 (2008).
35. Ovadia, O. et al. The effect of multiple N-methylation on intestinal permeability of peptides. Mol. Pharmaceutics 8, 479-487 (2011).
36. Biron, E., Chatterjee, J. & Kessler, H. Optimized selective N-methylation of peptides on solid support. J. Pept. Sci. 12, 213-219 (2006). (Pubitemid 43349362)
37. Coin, I., Beyermann, M. & Bienert, M. Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences. Nat. Protoc. 2, 3247-3256 (2007).
38. Fukuyama, T., Jow, C.-K. & Cheung, M. 2- and 4- Nitrobenzenesulfonamides: exceptionally versatile means for preparation of secondary amines and protection of amines. Tetrahedron Lett. 36, 6373-6374 (1995).
39. Patgiri, A., Menzenski, M.Z., Mahon, A.B. & Arora, P.S. Solid-phase synthesis of short a-helices stabilized by the hydrogen bond surrogate approach. Nat. Protoc. 5, 1857-1865 (2010).
40. Kim, Y.W., Grossmann, T.N. & Verdine, G.L. Synthesis of all-hydrocarbon stapled a-helical peptides by ring-closing olefin metathesis. Nat. Protoc. 6, 761-771 (2011).
41. Malesevic, M., Strijowski, U., Bächle, D. & Sewald, N. An improved method for the solution cyclization of peptides under pseudo-high dilution conditions. J. Biotechnol. 112, 73-77 (2004). (Pubitemid 39037388)
42. Chatterjee, J., Mierke, D. & Kessler, H. N-methylated cyclic pentaalanine peptides as template structures. J. Am. Chem. Soc. 128, 15164-15172 (2006). (Pubitemid 44868074)